Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

THE TURNOVER OF ENDOGENOUSLY LABELED CATECHOLAMINE IN SEVERAL REGIONS OF THE SYMPATHETIC NERVOUS SYSTEM

W. R. Burack and P. R. Draskóczy
Journal of Pharmacology and Experimental Therapeutics April 1964, 144 (1) 66-75;
W. R. Burack
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. R. Draskóczy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The rate of turnover of radioactive catecholamine in several regions of the sympathetic nervous system of mice has been measured by a technique involving endogenous labeling. Catecholamine storage sites were labeled by the intravenous administration of radioactive dopa or tyrosine, both precursors of catecholamine, in amounts insufficient to cause measurable change in the catecholamine content of the tissues under study. The subsequent fall in specific activity served as an index of the rate of turnover.

Conversion of DL-dopa-H3 into catecholamine proceeded very quickly; 4 hours after it had been injected, dopa-H3 had practically disappeared from blood and tissues and nearly all of the labeled catecholamine in the brain, heart, liver and adrenal gland was norepinephrine and/or epinephrine.

Specific activity of catecholamine in each organ was determined at intervals up to 4 days. In brain, liver and heart specific activity fell steeply at first (t½ = 4 to 8 hours) then gressively more slowly so that after 24 hours t½ = 18 hours. This implies either that the labeled catecholamine was distributed in more than one pool, each of which was turning over at a different rate and/or that catecholamine stores were nonhomogeneously labeled. In adrenal glands specific activity of catecholamine either rose or did not change during the first 8 hours after dopa-H3 was injected, probably because circulating catecholamine of high specific activity was being taken up and stored. From 8 hours to 3 days specific activity fell at a disappearance half-time of about 1 week.

The disappearance curve for spleen may not for the first 6 hours be taken to represent change in specific activity of beta-bydroxylated catecholamine. However, after this time the specific activity diminished with a t½ of approximately 24 hours.

When C14- or H3-tyrosine was given intravenously as precursor, catecholamine in brain was more heavily labeled than in any of the other organs which were studied. The rate of fall of specific activity in the adrenal medulla closely resembled that observed when labeling was with dopa-H3. The disappearance curves for heart, liver and brain lacked an initial rapid fall but after 24 hours the slopes were similar to those found when dopa-H3 was used as precursor.

Footnotes

    • Received August 27, 1962.
    • Accepted November 27, 1963.
  • The Williams & Wilkins Company

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 144, Issue 1
1 Apr 1964
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE TURNOVER OF ENDOGENOUSLY LABELED CATECHOLAMINE IN SEVERAL REGIONS OF THE SYMPATHETIC NERVOUS SYSTEM
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

THE TURNOVER OF ENDOGENOUSLY LABELED CATECHOLAMINE IN SEVERAL REGIONS OF THE SYMPATHETIC NERVOUS SYSTEM

W. R. Burack and P. R. Draskóczy
Journal of Pharmacology and Experimental Therapeutics April 1, 1964, 144 (1) 66-75;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

THE TURNOVER OF ENDOGENOUSLY LABELED CATECHOLAMINE IN SEVERAL REGIONS OF THE SYMPATHETIC NERVOUS SYSTEM

W. R. Burack and P. R. Draskóczy
Journal of Pharmacology and Experimental Therapeutics April 1, 1964, 144 (1) 66-75;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Interaction of Diclofenac and Quinidine in Monkeys: Stimulation of Diclofenac Metabolism
  • Is Hydroxylamine-Induced Cytotoxicity a Valid Marker for Hypersensitivity Reactions to Sulfamethoxazole in Human Immunodeficiency Virus-Infected Individuals?
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics